ArticleCancer biology & therapy2019

Frontline immunotherapy treatment with nivolumab and ipilimumab in metastatic renal cell cancer: a new standard of care.

Amanda Nizam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.